Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocept Inc (NQ: BIOC )

3.880 USD UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 512
Open 3.880
Bid (Size) 3.810 (1)
Ask (Size) 3.880 (2)
Prev. Close 3.880
Today's Range 3.880 - 3.880
52wk Range 3.260 - 8.380
Shares Outstanding 14,722,958
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biocept to Present at the LD Micro Main Event on October 13
Biocept to present at LD Micro Main Event 
From Business Wire News Releases
Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic
Biocept provides on-campus COVID-19 testing to over 30 California community colleges, as students and staff return to in-person learning. 
From Business Wire News Releases

Performance

YTD
-18.14%
-18.14%
1 Month
-4.67%
-4.67%
3 Month
-6.28%
-6.28%
6 Month
-23.47%
-23.47%
1 Year
-11.01%
-11.01%

More News

Read More
Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-BlockerTM Technology to Detect Rare Cancer Mutations
From Business Wire News Releases
Biocept to Present at Four Virtual Investor Conferences in September
From Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
Tags STAB Partner Content News
From Benzinga
Biocept’s CNSide Assay Identifies Tumor Cells and Actionable Treatment Biomarkers from Cerebrospinal Fluid in Patients with Metastatic Non-Small Cell Lung Cancer
From Business Wire News Releases
7 of the Best Penny Stocks to Buy Coming Into Year-End
Tags DGX BIOC XELA
From InvestorPlace
Biocept Reports Second Quarter 2021 Financial Results
From Business Wire News Releases
Friday Sector Laggards: Railroads, Diagnostics
Tags Stocks
From Market News Video
Investors React Positively To Study Data Of Biocept's Cerebrospinal Fluid Assay
Tags Market News Health Care Long Ideas
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.